Compare HITI & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HITI | RPID |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.6M | 204.3M |
| IPO Year | 2021 | 2021 |
| Metric | HITI | RPID |
|---|---|---|
| Price | $2.22 | $1.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $6.13 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 619.5K | 133.5K |
| Earning Date | 06-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $33,587,000.00 |
| Revenue This Year | $23.73 | $19.12 |
| Revenue Next Year | $12.80 | $18.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $2.13 | $1.66 |
| 52 Week High | $4.06 | $4.94 |
| Indicator | HITI | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 40.68 | 30.06 |
| Support Level | N/A | $1.66 |
| Resistance Level | $2.50 | $2.46 |
| Average True Range (ATR) | 0.12 | 0.12 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 1.14 | 4.90 |
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.